查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球细胞分拣市场 - 2023-2030年
市场调查报告书
商品编码
1297797

全球细胞分拣市场 - 2023-2030年

Global Cell Sorting Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球细胞分拣市场在2022年达到2.365亿美元，预计到2030年将见证有利可图的增长，达到3.898亿美元。在2023-2030年的预测期间，全球细胞分拣市场预计将呈现6.6%的复合增长率。

细胞分选在研究、临床诊断和治疗方面有许多应用。它使分离稀有细胞群成为可能，包括干细胞或循环肿瘤细胞，以便进一步分析。此外，它使纯化特定的细胞类型更容易，用于治疗，如开发基于细胞的药物或研究免疫细胞群。

然而，设备的高成本、严格的法规、熟练人员的缺乏以及发展中国家对细胞分拣技术的认识不足是阻碍细胞分拣市场增长的一些因素。

市场动态

慢性疾病负担的上升在预测期内推动了全球细胞分拣市场的增长

近60%的美国成年人患有至少一种慢性疾病。美国的主要死因包括糖尿病、癌症和心血管疾病等慢性疾病。心脏病、癌症、中风、慢性阻塞性肺病和糖尿病占所有死亡人数的三分之二以上。

根据CDC的数据，全国每年3.8万亿美元的医疗费用中，有90%是由慢性病患者和精神健康问题引起的。根据对抗慢性病伙伴关系最近的一份报告，到2030年，美国治疗七种最流行的慢性病的费用每年将达到2万亿美元，或每人8,600美元。根据同一份报告，减少有害行为可能每年防止110万人死亡。

不断增长的生物制药业在预测期内推动了全球细胞分拣市场的增长

美国最大的产业之一是生物制药，每年价值数十亿美元，对美国经济和使用其产品的病人至关重要。由于CDMO生物制品公司的出现，这项业务正在经历巨大的扩张，这些公司比以前更快地产生药品。

这个行业的扩张也归因于世界人口的扩大。世界人口的需求增加了生物制药企业的压力，但也让它吸引了更多的投资，提高了利润率，并进行了扩张。

个性化医疗的扩展提供了全球细胞分选市场的增长机会

有了个性化医疗，就有可能将 "一刀切 "的诊断、用药和预防方法转变为个性化的方法。根据病人的独特特征进行有针对性的治疗是个性化医疗的目标。识别和分离特定的细胞类型以进行定制治疗，在很大程度上取决于细胞分拣技术。随着个性化医疗的发展，对细胞分选技术的需求预计将上升。

COVID-19影响分析

COVID-19大流行病对细胞分拣市场产生了积极影响。免疫反应的变异性和COVID-19对各种细胞类型的影响已经利用单细胞分析技术（包括细胞分选）进行了广泛的研究。这场大流行加强了单细胞分析技术，并通过强调理解单个细胞的特征和反应的需要而增加了对细胞分拣技术的需求。

俄乌冲突分析

俄乌战争对细胞分拣市场的影响是复杂和多面的。用于在受影响地区建设医疗基础设施的资源、注意力和资金可能会被冲突及其后果所转移。这可能会影响尖端技术，如细胞分拣，在医疗保健和研究背景下的采用和使用。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按技术抽查
  • 按产品和服务分类
  • 按应用分类
  • 按终端用户分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 越来越多的慢性病检测
    • 限制因素
      • 高成本和服务
    • 机会
      • 技术进步
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第六章：COVID-19分析

  • 对COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：人工智能分析

第九章：按技术分类

  • 荧光激活细胞分选(FACS)
  • 磁激活细胞分拣(MACS)
  • 微机电系统(MEMS) 微流控技术
  • 密度梯度离心法
  • 免疫密度细胞分离
  • 沉淀法
  • 其他

第十章：按产品和服务分类

  • 细胞分拣机
  • 细胞分拣试剂和消耗品
  • 细胞分拣服务

第十一章：按应用分类

  • 临床应用
  • 研究应用
    • 免疫学和癌症研究
    • 干细胞研究
    • 药物发现
    • 其他研究应用

第十二章：按终端用户分类

  • 研究机构
  • 制药和生物技术公司
  • 医院和临床测试实验室
  • 医学院和学术机构

第十三章 ：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第十四章：竞争格局

  • 竞争格局
  • 产品标杆
  • 公司份额分析
  • 主要发展和战略

第十五章 ：公司简介

  • Bio-Rad Laboratories, Inc.
    • 公司概述
    • 产品组合和说明
    • 财务概况
    • 主要发展情况
  • Sony Biotechnology Inc.
  • BD
  • Merck KGaA
  • Danaher Corporation
  • Miltenyi Biotec GmbH
  • Affymetrix, Inc
  • Sysmex Partec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Thermo Fisher Scientific

第16章 ：附录

简介目录
Product Code: BT1895

Market Overview

The Global Cell Sorting Market reached US$ 236.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 389.8 million by 2030. The Global Cell Sorting Market is expected to exhibit a CAGR of 6.6% during the forecast period 2023-2030.

Cell sorting has numerous applications in research, clinical diagnostics, and therapeutics. It makes it possible to separate rare cell groups, including stem cells or circulating tumor cells, for further analysis. Additionally, it makes it easier to purify particular cell types for therapeutic uses like developing cell-based medicines or researching immune cell populations.

However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.

Market Dynamics

The Rising Chronic Disease Burden is Boosting the Global Cell Sorting Market Growth During the Forecast Period

Nearly 60% of American adults suffer from at least one chronic illness. The major causes of death in the US include chronic diseases like diabetes, cancer, and cardiovascular disease. Heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes account for over two-thirds of all fatalities.

According to the CDC, 90% of the nation's $3.8 trillion in annual healthcare costs are attributable to persons with chronic illnesses and mental health issues. According to a recent report by the Partnership to Fight Chronic Disease, by 2030, the expense of treating the seven most prevalent chronic diseases in the United States will total $2 trillion annually or $8,600 per person. According to the same report, reducing harmful behaviors might prevent 1,100,000 deaths annually.

The Growing Biopharmaceutical Industry is Boosting the Global Cell Sorting Market Growth During the Forecast Period

One of the largest industries in America is biopharma, which is worth billions of dollars annually and is crucial to the American economy and the patients who use their products. This business is experiencing tremendous expansion due to the emergence of CDMO Biologics companies, which are generating pharmaceuticals more quickly than before.

The expansion of this industry is also attributed to an expanding world population. The demand from the world's population has increased pressure on the biopharma business, but it has also allowed it to attract more investment, increase profitability, and expand.

The Expansion of Personalized Medicine Provides the Global Cell Sorting Market Growth Opportunities

With personalized medicine, it's possible to transform a "one size fits all" approach to diagnosis, medication, and prevention into an individualized one. Targeted treatments based on unique patient traits are the goal of personalized medicine. Identifying and isolating particular cell types for customized therapeutics depend heavily on cell sorting technology. The demand for cell sorting technology is anticipated to rise as personalized medicine grows.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a positive impact on the cell sorting market. The variability of the immune response and the effects of COVID-19 on various cell types have been extensively studied using single-cell analytic techniques, including cell sorting. The pandemic has enhanced single-cell analysis techniques and increased demand for cell sorting technology by highlighting the need to comprehend individual cells' traits and reactions.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the cell sorting market is complex and multifaceted. Resources, attention, and finance for the construction of healthcare infrastructure in the impacted areas may be diverted by the conflict and its aftermath. This might affect how cutting-edge technologies, like cell sorting, are adopted and used in healthcare and research contexts.

Segment Analysis

The Global Cell Sorting Market is segmented based on technology, product and services, application, End-user, and region.

The Fluorescence-Activated Cell Sorting (FACS) Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period

The fluorescence-activated cell sorting (FACS) segment accounted for the highest market stake, accounting for approximately 43.6% of the cell sorting market in 2022. The flow cytometry technique, fluorescence-activated cell sorting (FACS), is specialized. Using the unique light scattering and fluorescence properties of each cell, it offers a way for dividing a heterogeneous mixture of living cells into two or more containers, one cell at a time.

It is a practical scientific tool since it allows for the quick, accurate, and quantitative recording of fluorescence signals from individual cells as well as the physical segregation of cells of specific interest.

Geographical Analysis

Increasing Collaborations And Product Launches by the Key Players, and Increasing FDA Approvals, Dominate the North American Region

North America is expected to dominate the cell sorting market, accounting for around 39.6%. The market player applies strategies such as product launches and collaboration to expand their business.

For instance, in January 2023, Thermo Fisher Scientific, the leader in serving science, launched the Bigfoot Spectral Cell Sorter in India. The groundbreaking cell sorting system combines spectral sorting and analysis with traditional sorting to produce quick, simple-to-use cell sorting.

Competitive Landscape

The major global players in the market include: Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific among others.

Why Purchase the Report?

  • To visualize the Global Cell Sorting Market segmentation based on the technology, product and services, application, End-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cell sorting market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Cell Sorting Market Report Would Provide Approximately 69 Tables, 70 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product and Services
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of chronic disease testing
    • 4.1.2. Restraints
      • 4.1.2.1. High costs and services
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Fluorescence-activated cell sorting (FACS)*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Magnetic-activated cell sorting (MACS)
  • 9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
  • 9.5. Density Gradient Centrifugation
  • 9.6. Immunodensity Cell Separation
  • 9.7. Sedimentation
  • 9.8. Others

10. By Product and Services

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 10.1.2. Market Attractiveness Index, By Product and Services
  • 10.2. Cell Sorters*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cell Sorting Reagents & Consumables
  • 10.4. Cell Sorting Services

11. By Application

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. Clinical Applications*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Research Applications
    • 11.3.1. Immunology & Cancer Research
    • 11.3.2. Stem Cell Research
    • 11.3.3. Drug Discovery
    • 11.3.4. Other Research Applications

12. By End user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 12.1.2. Market Attractiveness Index, By End user
  • 12.2. Research Institutes*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Pharmaceutical & Biotechnology Companies
  • 12.4. Hospitals and Clinical Testing Laboratories
  • 12.5. Medical Schools and Academic Institutions

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. The U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. The U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Bio-Rad Laboratories, Inc.*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. Sony Biotechnology Inc.
  • 15.3. BD
  • 15.4. Merck KGaA
  • 15.5. Danaher Corporation
  • 15.6. Miltenyi Biotec GmbH
  • 15.7. Affymetrix, Inc
  • 15.8. Sysmex Partec GmbH
  • 15.9. On-Chip Biotechnologies Co., Ltd.
  • 15.10. Thermo Fisher Scientific

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us